The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape
Author:
Martin Darren P,Weaver Steven,Tegally Houryiah,San Emmanuel James,Shank Stephen D,Wilkinson Eduan,Lucaci Alexander G,Giandhari Jennifer,Naidoo Sureshnee,Pillay Yeshnee,Singh Lavanya,Lessells Richard J,Gupta Ravindra K,Wertheim Joel O,Nekturenko Anton,Murrell Ben,Harkins Gordon W,Lemey Philippe,MacLean Oscar A,Robertson David L,de Oliveira Tulio,Kosakovsky Pond Sergei L, ,
Abstract
AbstractThe emergence and rapid rise in prevalence of three independent SARS-CoV-2 “501Y lineages’’, B.1.1.7, B.1.351 and P.1, in the last three months of 2020 prompted renewed concerns about the evolutionary capacity of SARS-CoV-2 to adapt to both rising population immunity, and public health interventions such as vaccines and social distancing. Viruses giving rise to the different 501Y lineages have, presumably under intense natural selection following a shift in host environment, independently acquired multiple unique and convergent mutations. As a consequence, all have gained epidemiological and immunological properties that will likely complicate the control of COVID-19. Here, by examining patterns of mutations that arose in SARS-CoV-2 genomes during the pandemic we find evidence of a major change in the selective forces acting on various SARS-CoV-2 genes and gene segments (such as S, nsp2 and nsp6), that likely coincided with the emergence of the 501Y lineages. In addition to involving continuing sequence diversification, we find evidence that a significant portion of the ongoing adaptive evolution of the 501Y lineages also involves further convergence between the lineages. Our findings highlight the importance of monitoring how members of these known 501Y lineages, and others still undiscovered, are convergently evolving similar strategies to ensure their persistence in the face of mounting infection and vaccine induced host immune recognition.
Publisher
Cold Spring Harbor Laboratory
Reference63 articles.
1. Althaus, C.L. , Baggio, S. , Reichmuth, M.L. , Hodcroft, E.B. , Riou, J. , Neher, R.A. , Jacquerioz, F. , Spechbach, H. , Salamun, J. , Vetter, P. , et al. (2021). A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa. MedRxiv. 2. Annavajhala, M.K. , Mohri, H. , Zucker, J.E. , Sheng, Z. , Wang, P. , Gomez-Simmonds, A. , Ho, D.D. , and Uhlemann, A.-C. (2021). A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York. MedRxiv. 3. Campbell, K.M. , Steiner, G. , Wells, D.K. , Ribas, A. , and Kalbasi, A. (2020). Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles. BioRxiv. 4. Cele, S. , Gazy, I. , Jackson, L. , Hwa, S.-H. , Tegally, H. , Lustig, G. , Giandhari, J. , Pillay, S. , Wilkinson, E. , Naidoo, Y. , et al. (2021). Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma. MedRxiv. 5. Collier, D.A. , De Marco, A. , Ferreira, I.A.T.M. , Meng, B. , Datir, R. , Walls, A.C. , Kemp S, S.A. , Bassi, J. , Pinto, D. , Fregni, C.S. , et al. (2021). SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies. MedRxiv.
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|